• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ras 信号通路介导鼻咽癌对西妥昔单抗的耐药性。

The Ras signaling pathway mediates cetuximab resistance in nasopharyngeal carcinoma.

机构信息

Department of Oncology, Nanfang Hospital, Guangzhou 510515, China.

出版信息

Biomed Pharmacother. 2011 Jun;65(3):168-74. doi: 10.1016/j.biopha.2011.02.005. Epub 2011 May 5.

DOI:10.1016/j.biopha.2011.02.005
PMID:21602020
Abstract

This work aimed to investigate the role of the Ras signaling pathway in cetuximab resistance in human nasopharyngeal carcinoma (hNPC). An hNPC 5-8F cell line was induced by stepwise exposure to increasing doses of cetuximab. Western blot was conducted to detect protein levels. Our results are as follows: cetuximab-resistant hNPC 5-8F/Erbitux cell lines were successfully developed. After treatment with cetuximab for 3 and 5 d, the RI was 1.2 and 1.1, respectively. Compared with the 5-8F cells, the protein expression levels of H-ras, JNK/P-JNK, P-ERK1/2, p38/P-p38, P-AKT, NF-κB p65/P-NF-κB p65 and c-fos were significantly increased in the 5-8F/Erbitux cells (P=0.000 for all); however, the protein expression levels of ERK1/2 and c-jun/P-c-jun were significantly decreased (P=0.000 for all) and AKT protein expression showed no significant change (P=0.176). After the 5-8F/Erbitux cells were transfected with H-ras shRNA, H-ras protein expression was significantly decreased (P=0.000) and cetuximab sensitivity improved. In contrast, in the 5-8F/Erbitux+siH-ras cells, protein expression levels of P-ERK1/2, P-JNK, P-AKT and NF-κB p65/P-NF-κB p65 were significantly decreased (P=0.000 for all). Additionally, protein expression levels of JNK, ERK1/2, p38/P-p38 and c-jun/P-c-jun were significantly increased (P=0.000 for all), but protein expression levels of AKT and c-fos did not change significantly (P=0.061 and P=0.068, respectively). In conclusion, the activation of the H-ras/ERK1/2, H-ras/JNK and PI3K-AKT signaling pathways is closely associated with cetuximab resistance in 5-8F/Erbitux cells. NF-κB is activated in 5-8F/Erbitux cells without activation of c-jun.

摘要

本研究旨在探讨 Ras 信号通路在人鼻咽癌(hNPC)中西妥昔单抗耐药中的作用。通过逐步暴露于递增剂量的西妥昔单抗诱导 hNPC 5-8F 细胞系。采用 Western blot 检测蛋白水平。结果如下:成功建立了西妥昔单抗耐药的 hNPC 5-8F/Erbitux 细胞系。用西妥昔单抗处理 3 和 5 d 后,RI 分别为 1.2 和 1.1。与 5-8F 细胞相比,5-8F/Erbitux 细胞中 H-ras、JNK/P-JNK、P-ERK1/2、p38/P-p38、P-AKT、NF-κB p65/P-NF-κB p65 和 c-fos 的蛋白表达水平显著增加(均 P=0.000);然而,ERK1/2 和 c-jun/P-c-jun 的蛋白表达水平显著降低(均 P=0.000),AKT 蛋白表达无明显变化(P=0.176)。转染 H-ras shRNA 后,5-8F/Erbitux 细胞 H-ras 蛋白表达显著降低(P=0.000),西妥昔单抗敏感性提高。相反,在 5-8F/Erbitux+siH-ras 细胞中,P-ERK1/2、P-JNK、P-AKT 和 NF-κB p65/P-NF-κB p65 的蛋白表达水平均显著降低(均 P=0.000)。此外,JNK、ERK1/2、p38/P-p38 和 c-jun/P-c-jun 的蛋白表达水平显著增加(均 P=0.000),但 AKT 和 c-fos 的蛋白表达水平无明显变化(P=0.061 和 P=0.068)。综上所述,H-ras/ERK1/2、H-ras/JNK 和 PI3K-AKT 信号通路的激活与 5-8F/Erbitux 细胞中的西妥昔单抗耐药密切相关。在 5-8F/Erbitux 细胞中,NF-κB 被激活而 c-jun 未被激活。

相似文献

1
The Ras signaling pathway mediates cetuximab resistance in nasopharyngeal carcinoma.Ras 信号通路介导鼻咽癌对西妥昔单抗的耐药性。
Biomed Pharmacother. 2011 Jun;65(3):168-74. doi: 10.1016/j.biopha.2011.02.005. Epub 2011 May 5.
2
[Effects of silencing H-ras gene by RNA interference on cetuximab-sensitivity of cetuximab-resistant human nasopharyngeal carcinoma cells].[RNA干扰沉默H-ras基因对西妥昔单抗耐药的人鼻咽癌细胞西妥昔单抗敏感性的影响]
Zhonghua Zhong Liu Za Zhi. 2011 Aug;33(8):574-8.
3
Development of cetuximab-resistant human nasopharyngeal carcinoma cell lines and mechanisms of drug resistance.人鼻咽癌西妥昔单抗耐药细胞系的建立及其耐药机制。
Biomed Pharmacother. 2010 Oct;64(8):550-8. doi: 10.1016/j.biopha.2010.03.003. Epub 2010 Jul 13.
4
[Relationship between the insulin-like growth factor 1 receptor signaling pathway and the resistance of nasopharyngeal carcinoma to cetuximab].胰岛素样生长因子1受体信号通路与鼻咽癌对西妥昔单抗耐药性的关系
Zhonghua Zhong Liu Za Zhi. 2010 Aug;32(8):575-9.
5
[Correlation between ras gene and the resistance of nasopharyngeal carcinoma to cetuximab].
Nan Fang Yi Ke Da Xue Xue Bao. 2010 Jun;30(6):1415-7.
6
PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells.在KRAS野生型、激素难治性前列腺癌细胞中,PTEN表达通过介导PI3K/AKT和RAS/RAF/MAPK下游信号传导来控制细胞对西妥昔单抗的反应。
Oncol Rep. 2009 Mar;21(3):731-5.
7
Nuclear Klf4 accumulation is associated with cetuximab drug-resistance and predicts poor prognosis of nasopharyngeal carcinoma.核 Klf4 积累与西妥昔单抗耐药性相关,并预测鼻咽癌的预后不良。
J Transl Med. 2018 Jul 4;16(1):183. doi: 10.1186/s12967-018-1561-0.
8
Sinodielide A exerts thermosensitizing effects and induces apoptosis and G2/M cell cycle arrest in DU145 human prostate cancer cells via the Ras/Raf/MAPK and PI3K/Akt signaling pathways.辛二酰二肽 A 通过 Ras/Raf/MAPK 和 PI3K/Akt 信号通路发挥热增敏作用,并诱导 DU145 人前列腺癌细胞凋亡和 G2/M 细胞周期阻滞。
Int J Mol Med. 2014 Feb;33(2):406-14. doi: 10.3892/ijmm.2013.1568. Epub 2013 Nov 27.
9
Docetaxel-induced apoptosis of human melanoma is mediated by activation of c-Jun NH2-terminal kinase and inhibited by the mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway.多西他赛诱导的人黑色素瘤细胞凋亡是由c-Jun氨基末端激酶的激活介导的,并受到丝裂原活化蛋白激酶细胞外信号调节激酶1/2通路的抑制。
Clin Cancer Res. 2007 Feb 15;13(4):1308-14. doi: 10.1158/1078-0432.CCR-06-2216.
10
Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.Rit是一种非脂质修饰的Ras相关蛋白,它可使NIH3T3细胞发生转化,而不激活ERK、JNK、p38丝裂原活化蛋白激酶(MAPK)或PI3K/Akt信号通路。
Oncogene. 2000 Sep 28;19(41):4685-94. doi: 10.1038/sj.onc.1203836.

引用本文的文献

1
Protein Farnesylation on Nasopharyngeal Carcinoma, Molecular Background and Its Potential as a Therapeutic Target.蛋白质法尼基化修饰在鼻咽癌中的作用、分子机制及其作为治疗靶点的潜力
Cancers (Basel). 2022 Jun 8;14(12):2826. doi: 10.3390/cancers14122826.
2
Functional Roles of JNK and p38 MAPK Signaling in Nasopharyngeal Carcinoma.JNK 和 p38 MAPK 信号通路在鼻咽癌中的功能作用。
Int J Mol Sci. 2022 Jan 20;23(3):1108. doi: 10.3390/ijms23031108.
3
LncRNA KCNQ1OT1 (potassium voltage-gated channel subfamily Q member 1 opposite strand/antisense transcript 1) aggravates acute kidney injury by activating p38/NF-κB pathway via miR-212-3p/MAPK1 (mitogen-activated protein kinase 1) axis in sepsis.
长链非编码 RNA KCNQ1OT1(钾电压门控通道亚家族 Q 成员 1 反义链/反义转录本 1)通过 miR-212-3p/MAPK1(丝裂原活化蛋白激酶 1)轴激活 p38/NF-κB 通路加重脓毒症急性肾损伤。
Bioengineered. 2021 Dec;12(2):11353-11368. doi: 10.1080/21655979.2021.2005987.
4
Prognostic analysis of patients with locally advanced nasopharyngeal carcinoma following intensity modulated radiation therapy.局部晚期鼻咽癌患者调强放疗后的预后分析
Oncol Lett. 2018 Apr;15(4):4445-4450. doi: 10.3892/ol.2018.7850. Epub 2018 Jan 24.
5
Pyruvate dehydrogenase B promoted the growth and migration of the nasopharyngeal carcinoma cells.丙酮酸脱氢酶B促进了鼻咽癌细胞的生长和迁移。
Tumour Biol. 2016 Aug;37(8):10563-9. doi: 10.1007/s13277-016-4922-4. Epub 2016 Feb 8.
6
Multiple oncogenic mutations related to targeted therapy in nasopharyngeal carcinoma.鼻咽癌中与靶向治疗相关的多种致癌突变。
Chin J Cancer. 2015 Apr 8;34(4):177-83. doi: 10.1186/s40880-015-0011-0.
7
Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell lines.MEK 抑制剂 selumetinib(AZD6244; ARRY-142886)在鼻咽癌细胞系中的活性。
Invest New Drugs. 2013 Feb;31(1):30-8. doi: 10.1007/s10637-012-9828-4. Epub 2012 May 8.